Shamburg News · 8-K filed Nov 10, 2026, 4:30 PM EST
Intelligent Bio Solutions Reports Record Fiscal First Quarter 2027 Revenue of $1.39 Million
INBS · INTELLIGENT BIO SOLUTIONS INC.
- Earnings
- Materiality: high
Intelligent Bio Solutions Inc. reported revenue of $1,391,835 for the fiscal first quarter ended September 30, 2026, up 25% year-over-year, and a gross profit margin of 54.5%, up from 46.6% a year earlier. The Company reported a net loss attributable to Intelligent Bio Solutions Inc. of $(2,658,302), or $(0.86) per share, basic and diluted. The press release also states that the Company submitted its FDA 510(k) premarket notification on September 9, 2026.
Source: SEC EDGAR, Form 8-K, Item 2.02, accession 0001493152-26-050982.
Written from the filing by Shamburg Markets. Figures are as reported by the company.